News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
400,826 Results
Type
Article (26517)
Company Profile (60)
Press Release (374249)
Multimedia
Podcasts (38)
Webinars (8)
Section
Business (104419)
Career Advice (457)
Deals (16892)
Drug Delivery (57)
Drug Development (47803)
Employer Resources (47)
FDA (12399)
Job Trends (8510)
News (186510)
Policy (19537)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (1781)
Accelerated approval (30)
ADA (31)
Adcomms (11)
Allergies (150)
Alliances (26827)
ALS (131)
Alzheimer's disease (1050)
Antibody-drug conjugate (ADC) (292)
Approvals (12933)
Artificial intelligence (414)
ASCO (206)
Autoimmune disease (205)
Automation (14)
Bankruptcy (142)
Best Places to Work (6892)
BIO (25)
BIOSECURE Act (5)
Biosimilars (98)
Biotechnology (39)
Bladder cancer (163)
Brain cancer (47)
Breast cancer (527)
Cancer (4034)
Cardiovascular disease (333)
Career advice (419)
Career pathing (17)
CAR-T (168)
CDC (34)
Celiac Disease (3)
Cell therapy (463)
Cervical cancer (40)
Clinical research (44308)
Collaboration (1112)
Commercialization (1)
Company closure (1)
Compensation (329)
Complete response letters (25)
COVID-19 (1578)
CRISPR (50)
C-suite (726)
Cystic fibrosis (67)
Data (5862)
Decentralized trials (2)
Denatured (23)
Depression (128)
Dermatology (71)
Diabetes (422)
Diagnostics (3923)
Digital health (43)
Diversity (7)
Diversity, equity & inclusion (13)
Drug discovery (123)
Drug pricing (102)
Drug shortages (24)
Duchenne muscular dystrophy (158)
Earnings (39694)
Editorial (36)
Employer branding (6)
Employer resources (47)
Events (55902)
Executive appointments (684)
FDA (15386)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (10)
Frontotemporal dementia (15)
Funding (952)
Gene editing (97)
Generative AI (24)
Gene therapy (343)
GLP-1 (618)
Government (3180)
Grass and pollen (4)
Guidances (261)
Healthcare (12328)
Hematology (128)
HIV (57)
Huntington's disease (28)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (61)
Immunology and inflammation (96)
Immuno-oncology (57)
Indications (152)
Infectious disease (1771)
Inflammatory bowel disease (140)
Inflation Reduction Act (7)
Influenza (70)
Intellectual property (153)
Interviews (42)
IPO (7081)
IRA (23)
Job creations (1851)
Job search strategy (382)
JPM (19)
Kidney cancer (15)
Labor market (49)
Layoffs (207)
Leadership (10)
Legal (3648)
Liver cancer (74)
Longevity (12)
Lung cancer (624)
Lymphoma (326)
Machine learning (29)
Management (17)
Manufacturing (418)
Marketing (2)
MASH (137)
Medical affairs (1)
Medical device (13545)
Medtech (13706)
Mergers & acquisitions (10465)
Metabolic disorders (995)
mRNA (93)
Multiple sclerosis (126)
NASH (12)
Neurodegenerative disease (229)
Neuropsychiatric disorders (55)
Neuroscience (2018)
NextGen: Class of 2026 (3937)
Non-profit (2853)
Now hiring (44)
Obesity (405)
Opinion (110)
Ovarian cancer (175)
Pain (195)
Pancreatic cancer (217)
Parkinson's disease (229)
Partnered (19)
Patents (296)
Patient recruitment (570)
Peanut (50)
People (36310)
Pharmaceutical (17)
Pharmacy benefit managers (19)
Phase 1 (12728)
Phase 2 (19207)
Phase 3 (15721)
Pipeline (6094)
Policy (145)
Postmarket research (1670)
Preclinical (3903)
Press Release (18)
Prostate cancer (247)
Psychedelics (31)
Radiopharmaceuticals (223)
Rare diseases (619)
Real estate (2874)
Recruiting (19)
Regulatory (16632)
Reports (20)
Research institute (1684)
Resumes & cover letters (51)
Rett syndrome (26)
RNA editing (9)
RSV (50)
Schizophrenia (144)
Series A (153)
Series B (110)
Service/supplier (2)
Sickle cell disease (62)
Special edition (8)
Spinal muscular atrophy (109)
Sponsored (17)
Startups (2144)
Stomach cancer (11)
Supply chain (74)
Tariffs (27)
The Weekly (15)
Vaccines (571)
Venture capital (35)
Weight loss (270)
Women's health (90)
Worklife (4)
Date
Today (64)
Last 7 days (269)
Last 30 days (1383)
Last 365 days (16255)
2026 (8569)
2025 (16466)
2024 (19843)
2023 (22732)
2022 (30680)
2021 (32981)
2020 (32189)
2019 (28410)
2018 (21810)
2017 (18904)
2016 (18110)
2015 (21193)
2014 (16024)
2013 (13241)
2012 (14349)
2011 (14622)
2010 (13181)
Location
Africa (372)
Alabama (34)
Alaska (2)
Arizona (231)
Arkansas (12)
Asia (26003)
Australia (4119)
California (6959)
Canada (2281)
China (1077)
Colorado (359)
Connecticut (367)
Delaware (312)
Europe (51049)
Florida (1170)
Georgia (290)
Hawaii (1)
Idaho (35)
Illinois (780)
India (43)
Indiana (472)
Iowa (12)
Japan (446)
Kansas (98)
Kentucky (26)
Louisiana (43)
Maine (28)
Maryland (1036)
Massachusetts (4660)
Michigan (184)
Minnesota (534)
Mississippi (6)
Missouri (94)
Montana (20)
Nebraska (23)
Nevada (81)
New Hampshire (79)
New Jersey (2414)
New Mexico (10)
New York (1978)
North Carolina (981)
North Dakota (4)
Northern California (3401)
Ohio (262)
Oklahoma (10)
Oregon (28)
Pennsylvania (1625)
Puerto Rico (17)
Rhode Island (38)
South America (528)
South Carolina (78)
Southern California (2867)
Tennessee (164)
Texas (1319)
United States (26850)
Utah (239)
Virginia (189)
Washington D.C. (52)
Washington State (494)
West Virginia (4)
Wisconsin (83)
Wyoming (1)
400,826 Results for "rakuten medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Rakuten Medical Announces Executive Leadership Transition to Enhance Operational Execution and Organizational Discipline as a Global, Scalable Biotech Company
June 10, 2026
·
7 min read
Press Releases
Rakuten Medical and LOTTE Biologics Sign Manufacturing Agreement to Support Biopharmaceuticals in Global Oncology Program
January 14, 2026
·
5 min read
Press Releases
Rakuten Medical Raises $100 Million in Oversubscribed Series F to Accelerate Development Toward U.S. Regulatory Approval
January 7, 2026
·
10 min read
Press Releases
Rakuten Medical Expands Academic Access to IR700 Dye Through Fee-Only Provision, Greater Publication Freedom and Expanded IP & Commercialization Opportunities
January 21, 2026
·
6 min read
Press Releases
Rakuten Medical Selected to Participate in FDA CEO Forum in San Diego
June 16, 2025
·
5 min read
Press Releases
TempraMed Expands Strategic Partnership with McKesson Medical-Surgical to Accelerate North American Growth and Launch Full Portfolio Across B2B Channels
Integration into McKesson’s Medical-Surgical Solutions marketplace serving a nationwide customer base
June 30, 2026
·
6 min read
Press Releases
Rakuten Medical’s Anti-PD-L1 Antibody-IR700 Conjugate, RM-0256, Selected for AMED Funding
June 5, 2025
·
7 min read
Biotech Beach
Rakuten Medical Announces Poster Presentation and Booth Exhibition at ASCO 2024 Annual Meeting
Rakuten Medical, Inc today announced that it will present a poster at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (ASCO 2024), which will be held in Chicago, Illinois from May 31 through June 4, 2024.
May 9, 2024
·
5 min read
Press Releases
Rakuten Medical Announces Trial in Progress Poster Presentation at ASCO 2025 and Enrollment Expansion to Taiwan for Global Phase 3 ASP-1929-381
May 23, 2025
·
7 min read
Biotech Beach
Rakuten Medical Closes $119 Million Series E Financing to Further Develop its Alluminox™ Platform
Rakuten Medical, Inc. announced the completion of a $119 million Series E preferred stock financing, including $45 million in new capital and the conversion of $74 million of convertible promissory notes with accrued interest.
March 6, 2024
·
7 min read
1 of 40,083
Next
